MedPath

Effectivity of 1 Finger Tip Unit Compared to 2 Finger Tip Units 0.05% Tretinoin Cream

Not Applicable
Conditions
Photoaging
Interventions
Drug: 0.05% Tretinoin
Registration Number
NCT05004909
Lead Sponsor
Dr.dr.Irma Bernadette, SpKK (K)
Brief Summary

This clinical study will compare the efficacy of using one fingertip unit and two fingertip units of 0.05% before and after 30% trichloroacetic acid chemical peel procedure for facial skin rejuvenation in 35-60 years old female patients with Glogau II-III skin classification.

Detailed Description

This study is an experimental study with a randomized controlled trial (RCT) design on patients who met the inclusion criteria. Group A will receive pretreatment in the form of 0.05% tretinoin cream which is used as much as one fingertip unit every night, and group B will receive the same cream which should be used as much as two fingertip units. This cream will be used for two weeks before the patients receive a chemical peeling therapy using 30% trichloroacetic acid. The results of therapy will mainly be assessed based on the Dermoscopic Photoaging Scale (DPAS), as well as visual analog scale (VAS) for subjective symptoms and Clinician Erythema Assessment Scale (CEA) for erythema.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
46
Inclusion Criteria
  • Female patients aged 35-60 years old
  • Patients with Glogau II-III skin classification
  • Patients are willing to participate in the study and sign an informed consent form
Exclusion Criteria
  • Patients with hypertrophic scars or keloid on the face
  • Patients with open wound or infection on the face
  • History of other topical treatment on the face within 1 month of enrollment
  • Pregnant or breastfeeding mother
  • Patients and/or their families are not willing to participate in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2 Fingertip Units 0.05% Tretinoin0.05% TretinoinSubjects were randomized to receive the instructions to use 2 fingertip units of 0.05% tretinoin cream for 2 weeks before the first chemical peeling. After that, this therapy is instructed to be used for 4 weeks after the chemical peeling procedure with 30% trichloroacetic acid until the scheduled evaluation.
1 Fingertip Unit 0.05% Tretinoin0.05% TretinoinSubjects were randomized to receive the instructions to use 1 fingertip unit of 0.05% tretinoin cream for 2 weeks before the first chemical peeling. After that, this therapy is instructed to be used for 4 weeks after the chemical peeling procedure with 30% trichloroacetic acid until the scheduled evaluation.
Primary Outcome Measures
NameTimeMethod
Change of Subjective Pain EvaluationBaseline(pre-chemical peeling procedure), immediately after chemical peeling procedure, and 4 weeks after chemical peeling procedure

using Visual Analog Scale (VAS). Scale range is 0-10, 0 indicates no pain and 10 indicates severe pain

Change in Skin ThicknessBaseline(pre-chemical peeling procedure) and 4 weeks after chemical peeling procedure

Evaluation with USG of epidermal and dermal layer (in pixels)

Change of Photoaged Skin ConditionBaseline(pre-chemical peeling procedure), immediately after chemical peeling procedure, and 4 weeks after chemical peeling procedure

using dermoscopic photoaging scale (DPAS). This DPAS assessment is based on yes or no rules on 11 criteria in four facial regions, namely left malar, right malar, forehead, and chin. The criteria were yellowish discoloration, white line, lentigo, hypo- and hyper-pigmented macules, telangiectasia, yellow papules, actinic keratosis, senile comedones, deep wrinkle, superficial wrinkle, and criss-cross wrinkle. Score range is 0-44 points.

Change of Erythema DegreeBaseline(pre-chemical peeling procedure), immediately after chemical peeling procedure, and 4 weeks after chemical peeling procedure

using Clinician Erythema Assessment Scale (CEA). Scale range is 0-4, 0 indicates no erythema and 4 indicates severe erythema

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Indonesia dr. Cipto Mangunkusumo Hospital

🇮🇩

Jakarta, Jakarta Pusat, Indonesia

© Copyright 2025. All Rights Reserved by MedPath